RGI offers state-of-the-art technologies, a comprehensive range of Preimplantation Genetic Testing (PGT) and embryology services.
PGT-A
for Aneuploidy
PGT-M
for Monogenic/Single Gene Defects
PGT-SR
for Structural Rearrangements
PGT-HLA
for Human Leukocyte Antigen
PGT-A
PGT-A enables selection of an embryo with a normal chromosome count, reducing the chance of failed implantation, an early miscarriage, or a child with a chromosome abnormality.
PGT-M
PGT-M allows for selection of embryos, free of genetic disorder while avoiding the difficult decision about the outcome of a pregnancy following abnormal prenatal test results. RGI tests for rare conditions, offering specific test set-ups not available at other labs.
PGT-SR
PGT-SR allows for a viable pregnancy, reducing or avoiding the chance of a failed implantation, miscarriage and/or the birth of a child with congenital anomalies, resulting from an unbalanced chromosome translocation.
PGT-HLA
PGT-HLA is requested by couples where a previous child is in need of a bone marrow or cord blood transplant due to a genetic disorder. In planning future pregnancy, not only is it desired to have a child without the disorder, but an HLA-compatible child whose umbilical cord blood can be used for stem cell transplantation, to provide normally functioning bone marrow.